Pharmacogenomic Precision Medicine: Best Practice Toolkit for Improving Patient Screening for Adult Metastatic Cancer Patients-Reference-Cited by-同舟云学术

Pharmacogenomic Precision Medicine: Best Practice Toolkit for Improving Patient Screening for Adult Metastatic Cancer Patients

Published: Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

,Stewart Rena

Abstract

Precision medicine utilizes pharmacogenomic testing as a therapeutic approach. Genomic testing can assess the impact of an individual's genome on their reaction to specific medications. The main objective is to find variants that may affect an individual's response to a given medication. The implementation of pharmacogenomics in oncology facilitates informed decision-making by clinicians in drug selection and dosage determination.

Publisher

University of St. Augustine for Health Sciences Library

Reference84 articles.

1. Abdullah-Koolmees, H., van Keulen, A. M., Nijenhuis, M., & Deneer, V. M. (2021). Pharmacogenomics guidelines: Overview and comparison of the dpwg, cpic, cpnds, and rnpgx guidelines. Frontiers in Pharmacology, 11. https://doi.org/10.3389/fphar.2020.595219

2. Abe, J., Lobo, J. M., Trifiletti, D. M., & Showalter, T. N. (2017). Providing guidance for genomics-based cancer treatment decisions: Insights from stakeholder engagement for post-prostatectomy radiation therapy. BMC Medical Informatics and Decision Making, 17(1). https://doi.org/10.1186/s12911-017-0526-1

3. Agarwala, V., Khozin, S., Singal, G., O'Connell, C., Kuk, D., Li, G., Gossai, A., Miller, V., & Abernethy, A. P. (2018). Real-world evidence in support of precision medicine: Clinico-genomic cancer data as a case study. Health Affairs, 37(5), 765-772. https://doi.org/10.1377/hlthaff.2017.1579

4. American Cancer Society. (2022). Oncogenes, tumor suppressor genes, and dna repair genes. American cancer society. https://www.cancer.org/healthy/cancer-causes/genetics/genes-and-cancer/oncogenes-tumor-suppressor-genes.html

5. Battaglin, F., Naseem, M., Lenz, H.-J., & Salem, M. E. (2018). Microsatellite instability in colorectal cancer: Overview of its clinical significance and novel perspectives. Clinical Advances in Hematology & Oncology: H&O, 16(11), 735-745. https://pubmed.ncbi.nlm.nih.gov/30543589/